Inventor · disambiguated record
Zacharia Cheruvallath
Also filed as: CHERUVALLATH ZACHARIA · CHERUVALLATH ZACHARIA S
29 granted patents·9 pending applications·316 citations·filing 1997–2024
96Inventor score
Files withISIS PHARMACEUTICALS INC15TAKEDA PHARMACEUTICALS CO9CHERUVALLATH ZACHARIA5CHERUVALLATH ZACHARIA S2METABASIS THERAPEUTICS INC2
Top patents by PatentIndex Score
38 records- 0193US9434743B2Indazole derivativesTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 6, 2016·20 cites·18 claims
- 0293US6242591B1Synthesis of sulfurized 2'-substituted oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2000·Granted Jun 5, 2001·45 cites·19 claims
- 0386US12005054B2Piperidinyl-3-(aryloxy)propanamides and propanoatesTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jun 11, 2024·1 cites·19 claims
- 0486US11045457B2Piperidinyl-3-(aryloxy)propanamides and propanoatesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jun 29, 2021·5 cites·21 claims
- 0585US5760209AProtecting group for synthesizing oligonucleotide analogsISIS PHARMACEUTICALS INC·Filed 1997·Granted Jun 2, 1998·72 cites·31 claims
- 0683US7227015B2Synthesis of sulfurized oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2001·Granted Jun 5, 2007·11 cites·20 claims
- 0781US7381736B2Thiazole and thiadiazole inhibitors of tyrosine phosphatasesMETABASIS THERAPEUTICS INC·Filed 2005·Granted Jun 3, 2008·7 cites·19 claims
- 0881US7378516B2Synthesis of sulfurized oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2004·Granted May 27, 2008·8 cites·9 claims
- 0978US6326478B1Process for the synthesis of oligomeric compoundsISIS PHARMACEUTICALS INC·Filed 1998·Granted Dec 4, 2001·33 cites·40 claims
- 1078US5902881AReagent useful for synthesizing sulfurized oligonucleotide analogsISIS PHARMACEUTICALS INC·Filed 1997·Granted May 11, 1999·14 cites·26 claims
- 1177US6114519ASynthesis of sulfurized oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1997·Granted Sep 5, 2000·40 cites·18 claims
- 1277US2025049772A1Piperidinyl-3-(aryloxy)propanamides and propanoatesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1376US9827255B2Fumagillol derivativesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 28, 2017·1 cites·37 claims
- 1475US6677471B2Intermediates for the synthesis of oligonucleotide analoguesISIS PHARMACEUTICALS INC·Filed 2002·Granted Jan 13, 2004·4 cites·7 claims
- 1575US6521775B2Process for the synthesis of oligomeric compoundsISIS PHARMACEUTICALS INC·Filed 2001·Granted Feb 18, 2003·4 cites·5 claims
- 1673US8163779B2Glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2007·Granted Apr 24, 2012·2 cites·18 claims
- 1772US8563730B2Pyrazole and fused pyrazole glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2009·Granted Oct 22, 2013·1 cites·52 claims
- 1871US8530499B2Glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2012·Granted Sep 10, 2013·2 cites·12 claims
- 1970US5959099AProtecting group for synthesizing oligonucleotide analogsISIS PHARMACEUTICALS INC·Filed 1998·Granted Sep 28, 1999·21 cites·22 claims
- 2069US8034822B2Glucokinase activatorsTAKEDA SAN DIEGO INC·Filed 2007·Granted Oct 11, 2011·1 cites·23 claims
- 2168US7723511B2Synthesis of sulfurized oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2008·Granted May 25, 2010·0 cites·13 claims
- 2267US5783690AProtecting group for synthesizing oligonucleotide analogsISIS PHARMACEUTICALS INC·Filed 1997·Granted Jul 21, 1998·16 cites·9 claims
- 2361US2025188037A1N-(pyrrolidin-3-yl or piperidin-4-yl)acetamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2460US10328089B2Fumagillol derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 25, 2019·0 cites·35 claims
- 2558US2025059207A16,6-fused heterocyclic compounds as mettl3 inhibitors858 THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2654US12428403B2N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonistsTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Sep 30, 2025·0 cites·33 claims
- 2754US2012225887A1Glucokinase ActivatorsCHERUVALLATH ZACHARIA·Filed 2012·Application pending·0 cites
- 2853US9139598B2Glucokinase activatorsTAKEDA CALIFORNIA INC·Filed 2013·Granted Sep 22, 2015·0 cites·51 claims
- 2952US2023150981A1N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as sstr4 agonistsTAKEDA PHARMACEUTICAL COMPNAY LTD·Filed 2021·Application pending·0 cites
- 3052US2016009735A1Glucokinase ActivatorsTAKEDA PHARMACEUTICAL·Filed 2015·Application pending·0 cites
- 3151US8173645B2Glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2008·Granted May 8, 2012·0 cites·11 claims
- 3251US2008200371A1Thiazole and thiadiazole inhibitors of tyrosine phosphatasesCHERUVALLATH ZACHARIA S·Filed 2008·Application pending·0 cites
- 3349US6399756B1Process for the synthesis of oligomeric compoundsISIS PHARMACEUTICALS INC·Filed 1999·Granted Jun 4, 2002·6 cites·52 claims
- 3443US9475816B2Substituted-1,4-dihydropyrazolo[4,3-b]indolesTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 25, 2016·0 cites·17 claims
- 3541US6040438AReagent useful for synthesizing sulfurized oligonucleotide analogsISIS PHARMACEUTICALS INC·Filed 1998·Granted Mar 21, 2000·2 cites·18 claims
- 3638US2006135483A1Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatasesCHERUVALLATH ZACHARIA S·Filed 2005·Application pending·0 cites
- 3737US2008070867A12-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine PhosphatasesMETABASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3836US6399831B1Reagent useful for synthesizing sulfurized oligonucleotide analogsISIS PHARMACEUTICALS INC·Filed 1999·Granted Jun 4, 2002·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Zacharia Cheruvallath files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →